6533b860fe1ef96bd12c302f

RESEARCH PRODUCT

Clinical and biological data on the use of hydroxychloroquine against SARS-CoV-2 could support the role of the NLRP3 inflammasome in the pathogenesis of respiratory disease

Gerardo MusuracaPaolo SilimbaniPaola Di CarloMariasanta NapolitanoGiovanni MartinelliClaudio CerchioneAlessandro Lucchesi

subject

2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Respiratory diseaseHydroxychloroquineInflammasomemedicine.diseaseVirologyPathogenesisSARS-CoV-2 inlfammosomehydroxycholoroquineInfectious DiseasesVirologyMedicinebusinessmedicine.drug

description

The use of hydroxychloroquine (HCL) has been very common in countries with a rapid spread of coronavirus disease 2019 (COVID-19), although controversial and the subject of heated scientific discussions with implications for the whole society. This article is protected by copyright. All rights reserved.

yearjournalcountryeditionlanguage
2020-07-06
10.1002/jmv.26217http://hdl.handle.net/10447/425628